Literature DB >> 32875675

One benefit of COVID-19 measures in Taiwan: The reduction of influenza infections and severe complications.

Yu-Lung Hsu1, Hsiao-Chuan Lin1,2, Hsiu-Mei Wei1, Huan-Cheng Lai1, Kao-Pin Hwang1,2.   

Abstract

Entities:  

Keywords:  COVID-19; hand hygiene; influenza; mask wearing

Mesh:

Year:  2020        PMID: 32875675      PMCID: PMC7578271          DOI: 10.1111/irv.12778

Source DB:  PubMed          Journal:  Influenza Other Respir Viruses        ISSN: 1750-2640            Impact factor:   4.380


× No keyword cloud information.
Dear Editor, Influenza viruses are transmitted through droplets and particle aerosols from the coughs and sneezes of infected people and through contact with surfaces that have been contaminated. In addition to receiving an influenza vaccine, wearing a mask and observing strict hand hygiene are essential to preventing influenza infection. The annual influenza season in Taiwan is typically from November to March. On January 21, 2020, the fourth week of 2020, Taiwan recorded its first case of COVID‐19. Because the 2003 SARS epidemic was traumatic for Taiwan, most people in Taiwan began practicing strict hand hygiene and wearing masks (regardless of whether they were sick). To prevent an outbreak of COVID‐19, Taiwan's CDC started to amend their mask‐wearing policy, and they encouraged the general public to observe strict hand hygiene and avoid visiting crowded spaces. Although aimed at reducing COVID‐19 transmission, these measures also reduced the transmission of influenza. We used data on both the 2018 to 2019 and 2019 to 2020 influenza seasons. These data on the weekly number of patients with seasonal influenza were accessed using the open data website of Taiwan's CDC. All patients in Taiwan who have received diagnoses from clinicians—whether on the basis of an observation of clinical symptoms or laboratory findings—have their diagnoses documented in the national health database. Student's t test was used to examine the difference in seasonal influenza rates before and after Taiwan's first case of COVID‐19. Relative to the same period in 2019, during the period after Taiwan's first COVID‐19 case, the number of people with influenza per week (86 177 vs 56 379, P = .003; Figure 1A) and the number of people with severe complications from influenza (43 vs 15, P = .004; Figure 1B) were significantly lower; the number of outpatients with influenza was significantly lower for all age groups (P < .01) (Figure 1C), and the number of patients admitted because of confirmed influenza‐related pneumonia per week was also significantly lower especially in younger groups (age < 15 years‐old), except 25 to 64 years old (74 vs 51, P = .17; Figure 1D). Relative to the period before the first COVID‐19 case, the number of people with influenza per week (86 167 vs 51 227, P < .001; Figure 1A) significantly decreased in the period after.
Figure 1

A, Number of patients with Influenza per week in the 2018 to 2019 (blue) and 2019 to 2020 (orange) Influenza seasons. B, Number of patients with severe complications from Influenza per week after the fourth week of 2019 (blue) and 2020 (orange). C, Average number of outpatients with Influenza per Week after the fourth week of 2019 (blue) and 2020 (orange), by Age. D, Average number of patients admitted because of confirmed Influenza‐related Pneumonia per Week After the Fourth Week of 2019 (blue) and 2020 (orange), by age

A, Number of patients with Influenza per week in the 2018 to 2019 (blue) and 2019 to 2020 (orange) Influenza seasons. B, Number of patients with severe complications from Influenza per week after the fourth week of 2019 (blue) and 2020 (orange). C, Average number of outpatients with Influenza per Week after the fourth week of 2019 (blue) and 2020 (orange), by Age. D, Average number of patients admitted because of confirmed Influenza‐related Pneumonia per Week After the Fourth Week of 2019 (blue) and 2020 (orange), by age Consistent with our results, Sakamoto et al noted lower seasonal influenza activity following the COVID‐19 outbreak in Japan. Our results were documenting the large decrease for all age groups especially in younger groups not only in weekly outpatients with influenza but also admissions due to confirmed influenza‐related pneumonia. The influenza vaccine is the most effective means of preventing influenza, and Taiwan's influenza vaccine policy has remained unchanged. The influenza vaccine also closely matched the dominant influenza virus during these 2 influenza seasons. Our results also indicated that strict personal hygiene habits, especially emphasizing in children and adolescents, are key to preventing influenza transmission. Therefore, one benefit of COVID‐19 measures in Taiwan is the reduction of influenza infections and complications.

AUTHOR CONTRIBUTIONS

Yu‐Lung Hsu: Conceptualization (lead); Data curation (equal); Formal analysis (equal); Investigation (equal); Methodology (equal); Project administration (equal); Writing‐original draft (lead); Writing‐review & editing (equal). Hsiao‐Chuan Lin: Conceptualization (equal); Formal analysis (equal); Methodology (equal); Validation (equal); Writing‐original draft (equal); Writing‐review & editing (equal). Hsiu‐Mei Wei: Conceptualization (equal); Data curation (equal); Formal analysis (equal); Writing‐review & editing (equal). Huan‐Cheng Lai: Conceptualization (equal); Data curation (equal); Formal analysis (equal); Writing‐review & editing (equal). Kao‐Pin Hwang: Conceptualization (equal); Methodology (equal); Supervision (lead); Validation (lead); Writing‐original draft (equal); Writing‐review & editing (lead).
  3 in total

1.  Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Authors:  Timothy M Uyeki; Henry H Bernstein; John S Bradley; Janet A Englund; Thomas M File; Alicia M Fry; Stefan Gravenstein; Frederick G Hayden; Scott A Harper; Jon Mark Hirshon; Michael G Ison; B Lynn Johnston; Shandra L Knight; Allison McGeer; Laura E Riley; Cameron R Wolfe; Paul E Alexander; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

2.  Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Japan.

Authors:  Haruka Sakamoto; Masahiro Ishikane; Peter Ueda
Journal:  JAMA       Date:  2020-05-19       Impact factor: 56.272

3.  One benefit of COVID-19 measures in Taiwan: The reduction of influenza infections and severe complications.

Authors:  Yu-Lung Hsu; Hsiao-Chuan Lin; Hsiu-Mei Wei; Huan-Cheng Lai; Kao-Pin Hwang
Journal:  Influenza Other Respir Viruses       Date:  2020-09-01       Impact factor: 4.380

  3 in total
  6 in total

1.  Changes in the incidence of contagious infectious skin diseases after the COVID-19 outbreak.

Authors:  E J Chun; J K Kim; S Y Yang; S S Kim; C W Kim
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-09-19       Impact factor: 9.228

2.  The Collateral Effect of COVID-19 on the Epidemiology of Airborne/Droplet-Transmitted Notifiable Infectious Diseases in Taiwan.

Authors:  Hung-Jen Tang; Chih-Cheng Lai; Chien-Ming Chao
Journal:  Antibiotics (Basel)       Date:  2022-04-03

Review 3.  Effects of COVID-19 prevention procedures on other common infections: a systematic review.

Authors:  Omid Dadras; Seyed Ahmad Seyed Alinaghi; Amirali Karimi; Mehrzad MohsseniPour; Alireza Barzegary; Farzin Vahedi; Zahra Pashaei; Pegah Mirzapour; Amirata Fakhfouri; Ghazal Zargari; Solmaz Saeidi; Hengameh Mojdeganlou; Hajar Badri; Kowsar Qaderi; Farzane Behnezhad; Esmaeil Mehraeen
Journal:  Eur J Med Res       Date:  2021-07-03       Impact factor: 2.175

4.  One benefit of COVID-19 measures in Taiwan: The reduction of influenza infections and severe complications.

Authors:  Yu-Lung Hsu; Hsiao-Chuan Lin; Hsiu-Mei Wei; Huan-Cheng Lai; Kao-Pin Hwang
Journal:  Influenza Other Respir Viruses       Date:  2020-09-01       Impact factor: 4.380

5.  The incremental burden of invasive pneumococcal disease associated with a decline in childhood vaccination using a dynamic transmission model in Japan: A secondary impact of COVID-19.

Authors:  Taito Kitano; Hirosato Aoki
Journal:  Comput Biol Med       Date:  2021-04-24       Impact factor: 6.698

6.  Decreased human respiratory syncytial virus activity during the COVID-19 pandemic in Japan: an ecological time-series analysis.

Authors:  Keita Wagatsuma; Iain S Koolhof; Yugo Shobugawa; Reiko Saito
Journal:  BMC Infect Dis       Date:  2021-08-03       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.